A new drug combination for rheumatoid arthritis treats the disease just as well as other intensive treatment strategies but with less medication and fewer side effects at a significantly lower cost.
Doctoral researcher Diederik De Cock (KU Leuven) describes the strategy in a new study published in Annals of Rheumatic Diseases.
Rheumatoid arthritis (RA) is a chronic auto-immune disease that causes pain and stiffness in the joints, fatigue, bone damage and, eventually, loss of mobility. RA afflicts around 1% of people in the western world; in Belgium, 80,000 to 100,000 people currently live with the disease.
Because there is no known cure for RA, physicians focus treatment on suppressing disease activity. Therapies have improved in recent years, and clinical studies show that intensive treatment of early RA can prevent joint damage and improve patients’ quality of life.
In the two-year study, called ‘CareRA’ (Care in early RA), researchers and clinicians in the rheumatology unit at University Hospitals Leuven examined various therapies for early RA. Their goal: to find the optimal combination and dosage of three commonly prescribed antirheumatic drugs (methotrexate, sulfasalazine and leflunomide) in combination with glucocorticoids (a class of steroid hormones).
The researchers divided 290 early RA patients into three treatment groups. Each group received a different combination therapy: ‘COBRA Classic’ (methotrexate, sulfasalazine and a high first dose of glucocorticoids), ‘COBRA Slim’ (methotrexate and a moderate dose of glucocorticoids) or ‘COBRA Avant-Garde’ (methotrexate, leflunomide and a moderate dose of glucocorticoids).
Fewer side effects
All three strategies showed a similarly high efficacy: disease remission was achieved in 7 in 10 patients after 16 weeks of treatment. But results for the strategies varied significantly when it came to side effects.
The new COBRA Slim strategy, which calls for the least amount of medication, had half as many side effects as the two other strategies – and was just as effective. The strategy would also be easier to implement in daily practice because it is less complicated.
A broader use of this strategy would lead to higher remission rates in the global early RA population and would probably reduce the need for expensive second-line antirheumatic treatment, say the researchers.
The Latest on: Rheumatoid arthritis
[google_news title=”” keyword=”rheumatoid arthritis” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Rheumatoid arthritis
- AbbVie Stock Falls As Company Warns of Continued Humira Sales Slumpon April 26, 2024 at 12:05 pm
AbbVie warned Friday that sales of its blockbuster arthritis drug, Humira, will continue to lose market share to biosimilars.
- Blood test finds knee osteoarthritis up to 8 years before it appears on X-rayson April 26, 2024 at 11:00 am
Detecting knee osteoarthritis with a blood test up to eight years before it appears on X-rays -- as researchers have done -- could lead to therapies that delay disease progression and restore joint ...
- Rheumatoid Arthritis and Osteoarthritis patients genetically susceptible for developing COPD, suggests studyon April 26, 2024 at 8:00 am
Rheumatoid Arthritis and Osteoarthritis patients are genetically susceptible to developing COPD, suggests a study published in the Frontiers in Medicine.Observational studies have reported ...
- Biogen's Tofidence Gets Positive CHMP Opinion For Rheumatoid Arthritis,Juvenile Arthritis & COVID-19on April 25, 2024 at 6:48 pm
Biogen Inc. (BIIB) said that the Committee for Medicinal Products for Human Use or CHMP of the European Medicines Agency or EMA ...
- Arthritis linked to blood cancer mutationson April 23, 2024 at 10:20 am
A team of Adelaide and U.S. researchers has discovered a link between a less common form of rheumatoid arthritis and gene mutations found in blood cancer.
- Woman's Doctor: Rheumatoid arthritis symptoms more severe among womenon April 22, 2024 at 2:30 pm
Women suffer more severe symptoms of rheumatoid arthritis than men, a recent study revealed. Natiki Shuron was diagnosed with rheumatoid arthritis about 10 years ago. "When I first started, I was all ...
- 'A wonder cell that's already widespread in our bodies could hold the key to treating arthritis'on April 21, 2024 at 10:02 am
A groundbreaking new study has helped to advance our understanding of the complex interplay between the cells which usually protect and lubricate our joints but which can turn nasty and inflammatory ...
- Rheumatoid Arthritis (RA) Rashon April 20, 2024 at 5:00 pm
She is board-certified in both rheumatology and internal medicine. Rheumatoid arthritis (RA) is an inflammatory disease that attacks healthy tissue in the joints, leading to swelling and reduced ...
- Tennis pro Danielle Collins opens up about retiring amid battle with endometriosis, rheumatoid arthritison April 19, 2024 at 12:28 pm
Collins was diagnosed in 2019 with rheumatoid arthritis, an autoimmune disease that causes painful swelling in the joints and can affect other parts of the body as well, according to the U.S. Centers ...
- Pannus and Rheumatoid Arthritis (RA): The Basicson April 16, 2024 at 5:01 pm
It most often results from rheumatoid arthritis (RA), which is an inflammatory disease that affects your joints. With an inflammatory disease, your immune system attacks healthy cells in your ...
via Bing News
